Goldman says Cepheid (CPHD -8.3%) is oversold, and the pullback may be a buying opportunity. The...

|By:, SA News Editor

Goldman says Cepheid (CPHD -8.3%) is oversold, and the pullback may be a buying opportunity. The firm says that despite the gloomy FY13 margin forecast, the company has a "healthy" long-term growth story. Its a leader in the rapid MDx market, and has a solid new prduct pipeline.